Heterocyclic prolinamide derivatives

Abstract

This invention is directed to novel heterocyclic prolinamide derivatives of Formula I,and pharmaceutically acceptable salts, solvates, solvates of the salt and prodrugs thereof, useful in the prevention (e.g., delaying the onset of or reducing the risk of developing) and treatment (e.g., controlling, alleviating, or slowing the progression of) of age-related macular degeneration (AMD) and related diseases of the eye. These diseases include dry-AMD, wet-AMD, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells. The invention disclosed herein is further directed to methods of prevention, slowing the progress of, and treatment of dry-AMD, wet-AMD, and geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells, comprising: administration of a therapeutically effective amount of compound of the invention. The compounds of the invention are inhibitors of HTRA1. Thus, the compounds of the invention are useful in the prevention and treatment of a wide range of diseases mediated (in whole or in part) by HTRA1. The compounds of the invention are also useful for inhibiting HTRA1 protease activity in an eye or locus of an arthritis or related condition.

What is claimed is: 
     
         1 . A compound of Formula (I): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof wherein: 
         W is selected from the group consisting of: —B(OH) 2  and —C(O)C(O)NR 7 R 8 ; 
         X is selected from the group consisting of: —O—, —S(O) p — and —N(C(O)OR 6 )—; 
         Y is selected from the group consisting of: —C(O)—, —SO 2 —, and —NHC(O)—; 
         R 1  is selected from the group consisting of:
 (a) —(CH 2 ) 0-6 -aryl, 
 (b) —(CH 2 ) 0-6 -heteroaryl, 
 (c) —(CH 2 ) 0-6 —C 3-8 cycloalkyl optionally substituted with phenyl, and 
 (d) —(CH 2 ) 0-6 -heterocyclyl optionally substituted with phenyl or oxo, 
 
         wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —CN, 
 (iii) —C 1-6 alkyl, 
 (iv) —C 0-6 alkyl-R 5 , 
 (v) —C 2-6 alkenyl, 
 (vi) —C 2-6 alkynyl, 
 (vii) —C(O)R 7 , 
 (viii) —CO 2 R 7 , 
 (ix) —CONR 7 R 8 , 
 (x) —OH, 
 (xi) —O—C 1-6 alkyl, 
 (xii) —O—C 0-6 alkyl-R 5 , 
 (xiii) —SH, 
 (xiv) —S(O) p —C 1-6 alkyl, 
 (xv) —S(O) p —C 0-6 alkyl-R 5 , 
 (xvi) —S(O) 2 NR 7 R 8 , 
 (xvii) —NO 2 , 
 (xviii) —NR 7 R 8 , 
 (xix) —NHC(O)R 7 , 
 (xx) —NHC(O)OR 7 , 
 (xxi) —NHC(O)NR 7 R 8 , 
 (xxii) —NHSO 2 C 1-6 alkyl, and 
 (xxiii) —NHSO 2 C 0-6 alkyl-R 5 , 
 
         wherein each of the alkyl group of choices (iii), (iv), (xi), (xii), (xiv), (xv), (xxii) and (xxiii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         R 2  is selected from the group consisting of:
 (a) —C 3-8 alkyl and 
 (b) —C 0-6 alkyl-R 5 , 
 
         wherein each of the alkyl group of choices (a) and (b) is optionally substituted with 1 to 5 substituents independently selected from:
 (i) -halogen, 
 (ii) -haloC 1-4 alkyl, 
 (iii) —NR 7 R 8 , 
 (iv) —OH, 
 (v) —O—C 1-4 alkyl, 
 (vi) —SH, 
 (vii) —S—C 1-4 alkyl; 
 (viii) —NR 7 SO 2 C 1-4 alkyl, and 
 (ix) —NR 7 C(O)OR 7 , 
 
         R 3a  is H, and R 3b  is selected from the group consisting of:
 (a) —H, 
 (b) —OH, 
 (c) -heteroaryl, 
 (d) —O-heteroaryl, 
 (e) -heterocycle, 
 (f) -aryl, and 
 (g) —O-aryl; 
 
         wherein each of the heteroaryl of choices (c) and (d), the heterocycle of choice (e) and the aryl of choices (f) and (g) is optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —(CH 2 ) 0-3 —NHSO 2 —C 1-4 alkyl, 
 (v) —(CH 2 ) 0-3 —SO 2 —C 1-4 alkyl, 
 (vi) —(CH 2 ) 0-3 —C(O)O—C 1-4 alkyl, and 
 (vii) —CN; and 
 
         wherein the heterocycle of choice (e) is additionally optionally substituted with 1 to 2 oxo groups; or 
         R 3a  and R 3b  together represent oxo; 
         each R 4  is independently selected from the group consisting of:
 (a) —C 1-4 alkyl, 
 (b) -haloC 1-4 alkyl, 
 (c) —OH, 
 (d) —O—C 1-4 alkyl, 
 (e) —O-haloC 1-4 alkyl, and 
 (f) -halogen; 
 
         each R 5  is independently selected from the group consisting of:
 (a) —C 3-12 cycloalkyl, 
 (b) -aryl, 
 (c) -heteroaryl, and 
 (d) -heterocyclyl, 
 
         wherein each of choices (a) to (d) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) —C 1-4 alkyl, 
 (ii) -halogen, 
 (iii) —NR 7 R 8 , 
 (iv) —OH, 
 (v) —O—C 1-4 alkyl, 
 (vi) —SH, and 
 (vii) —S—C 1-4 alkyl; 
 
         wherein each of the alkyl group of choices (i), (v) and (vii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         R 6  is selected from the group consisting of:
 (a) —C 1-6 alkyl, and 
 (b) —C 0-6 alkyl-aryl; 
 
         each R 7  and each R 8  are independently selected from the group consisting of:
 (a) —H, 
 (b) —C 1-6 alkyl, 
 (c) —C 0-6 alkyl-C 3-12 cycloalkyl, 
 (d) —C 0-6 alkyl-heterocyclyl, 
 (e) —C 0-6 alkyl-heteroaryl, 
 (f) —C 0-6 alkyl-aryl, 
 (g) —C 2-6 alkenyl, and 
 (h) —C 2-6 alkynyl, 
 
         wherein the alkyl group of choices (b)-(f), the alkenyl group of choice (g), the cycloalkyl group of choice (c), and the alkynyl group of (h) is optionally substituted with 1 to 3 groups independently selected from:
 (i) -halogen, 
 (ii) —C 1-4 alkyl, 
 (iii) —C(O)C 1-4 alkyl, 
 (iv) —OH, 
 (v) —OC 1-4 alkyl, 
 (vi) —SH, 
 (vii) —SC 1-4 alkyl, 
 (viii) —NH 2 , 
 (ix) —NH(C 1-4 alkyl), and 
 (x) —N(C 1-4 alkyl)(C 1-4 alkyl); or 
 
         R 7 , R 8  and the nitrogen atom to which they are attached together form a 3- to 7-membered monocyclic or 6- to 11-membered bicyclic heterocycle optionally having an additional heteroatom selected from O, S(O) p , and NR 9 , and wherein said heterocycle is optionally substituted with 1 to 2 groups independently selected from halogen; 
         R 9  is selected from the group consisting of:
 (a) —H, 
 (b) —C 1-4 alkyl, 
 (c) —C(O)—C 1-4 alkyl, 
 (d) —C(O)NH 2 , 
 (e) —C(O)—NH(C 1-4 alkyl), 
 (f) —C(O)—N(C 1-4 alkyl) 2 , and 
 (g) —C(O)O—C 1-4 alkyl; 
 
         R 10 , R 11 , and R 12  are independently selected from the group consisting of: H, halogen, —OH and —C 1-6  alkyl; or 
         R 10 , R 11  and the carbon atom to which they are attached together form a C 3-12 cycloalkyl or a heterocyclyl group; 
         k is 0, 1, 2, 3 or 4; 
         n and m are independently selected from 0, 1, 2 and 3, with the proviso that n+m is 0, 1, 2, 3 or 4; and 
         p is 0, 1 or 2. 
       
     
     
         2 . A compound of  claim 1  wherein
 R 1  is selected from the group consisting of:
 (a) -aryl, and 
 (b) -heteroaryl, 
 
 wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —CN, 
 (iii) —C 1-6 alkyl, 
 (iv) —C 0-6 alkyl-R 5 , 
 (v) —C 2-6 alkenyl, 
 (vi) —C 2-6 alkynyl, 
 (vii) —C(O)R 7 , 
 (viii) —CO 2 R 7 , 
 (ix) —CONR 7 R 8 , 
 (x) —OH, 
 (xi) —O—C 1-6 alkyl, 
 (xii) —O—C 0-6 alkyl-R 5 , 
 (xiii) —SH, 
 (xiv) —S(O) p —C 1-6 alkyl, 
 (xv) —S(O) p —C 0-6 alkyl-R 5 , 
 (xvi) —S(O) 2 NR 7 R 8 , 
 (xvii) —NO 2 , 
 (xviii) —NR 7 R 8 , 
 (xix) —NHC(O)R 7 , 
 (xx) —NHC(O)OR 7 , 
 (xxi) —NHC(O)NR 7 R 8 , 
 (xxii) —NHSO 2 C 1-6 alkyl, and 
 (xxiii) —NHSO 2 C 0-6 alkyl-R 5 , 
 
 wherein each of the alkyl group of choices (iii), (iv), (xi), (xii), (xiv), (xv), (xxii) and (xxiii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
 
     
     
         3 . A compound of  claim 1  or  claim 2  wherein
 R 3b  is selected from the group consisting of:
 (a) —OH, 
 (b) -heteroaryl, 
 (c) —O-heteroaryl, 
 (d) -heterocycle, 
 (e) -aryl, and 
 (f) —O-aryl; 
 
 wherein each of the heteroaryl of choices (b) and (c), the heterocycle of choice (d) and the aryl of choices (e) and (f) is optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
 wherein the heterocycle of choice (d) is additionally optionally substituted with 1 to 2 oxo groups; or 
 R 3a  and R 3b  together represent oxo. 
 
     
     
         4 . A compound of any one of  claims 1  through  3  wherein
 R 3b  is selected from the group consisting of:
 (a) —OH, 
 (b) -heteroaryl, 
 (c) —O-heteroaryl, and 
 (d) -heterocycle, 
 
 wherein each of the heteroaryl of choices (b) and (c), and the heterocycle of choice (d) is optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
 wherein the heterocycle of choice (d) is additionally optionally substituted with 1 to 2 oxo groups. 
 
     
     
         5 . A compound of any one of  claims 1  through  4  wherein
 R 3b  is selected from the group consisting of:
 (a) —OH, 
 (b) 
 
 
       
         
           
           
               
               
           
         
         
           (c) —O-heteroaryl, and 
           (d) 
         
       
       
         
           
           
               
               
           
         
         wherein HAr is heteroaryl and Hcyl is heterocycle, and HAr, heteroaryl of choice (c), and Hcyl are each optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein Hcyl is additionally optionally substituted with 1 to 2 oxo groups. 
       
     
     
         6 . A compound of any one of  claims 1  through  5  wherein
 R 3b  is selected from the group consisting of:
 (a) 
 
 
       
         
           
           
               
               
           
         
         
            and 
           (b) 
         
       
       
         
           
           
               
               
           
         
         wherein HAr is heteroaryl and Hcyl is heterocycle, and HAr and Hcyl are each optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein Hcyl is additionally optionally substituted with 1 to 2 oxo groups. 
       
     
     
         7 . A compound of any of  claims 1  through  6  wherein
 R 2  is —C 1-6 alkyl-R 5 , wherein the alkyl group is optionally substituted with 1 to 3 substituents independently selected from:
 (i) -halogen, 
 (ii) -haloC 1-4 alkyl, 
 (iii) —O—C 1-4 alkyl, 
 (iv) —S—C 1-4 alkyl. 
 
 
     
     
         8 . A compound of any of  claims 1  through  7  wherein
 R 5  is —C 3-12 cycloalkyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) —C 1-4 alkyl, 
 (ii) -halogen, 
 (iii) —O—C 1-4 alkyl, 
 (iv) —S—C 1-4 alkyl; 
 
 wherein each of the alkyl group of choices (i), (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
 
     
     
         9 . A compound of any of  claims 1 - 8  wherein W is —C(O)C(O)NR 7 R 8 . 
     
     
         10 . A compound of any of  claims 1 - 9  wherein X is —O— or —S(O) p —. 
     
     
         11 . A compound of  claim 1  having the formula (Ia): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof wherein: 
         W is selected from the group consisting of: —B(OH) 2  and —C(O)C(O)NR 7 R 8 ; 
         X is —O— or —S(O) p —; 
         Y is selected from the group consisting of: —C(O)—, —SO 2 —, and —NHC(O)—; 
         R 1  is selected from the group consisting of:
 (a) -aryl, 
 (b) -heteroaryl, 
 
         wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —CN, 
 (iii) —C 1-6 alkyl, 
 (iv) —C 0-6 alkyl-R 5 , 
 (v) —C 2-6 alkenyl, 
 (vi) —C 2-6 alkynyl, 
 (vii) —C(O)R 7 , 
 (viii) —CO 2 R 7 , 
 (ix) —CONR 7 R 8 , 
 (x) —OH, 
 (xi) —O—C 1-6 alkyl, 
 (xii) —O—C 0-6 alkyl-R 5 , 
 (xiii) —SH, 
 (xiv) —S(O) p —C 1-6 alkyl, 
 (xv) —S(O) p —C 0-6 alkyl-R 5 , 
 (xvi) —S(O) 2 NR 7 R 8 , 
 (xvii) —NO 2 , 
 (xviii) —NR 7 R 8 , 
 (xix) —NHC(O)R 7 , 
 (xx) —NHC(O)OR 7 , 
 (xxi) —NHC(O)NR 7 R 8 , 
 (xxii) —NHSO 2 C 1-6 alkyl, and 
 (xxiii) —NHSO 2 C 0-6 alkyl-R 5 , 
 
         wherein each of the alkyl group of choices (iii), (iv), (xi), (xii), (xiv), (xv), (xxii) and (xxiii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         R 3a  is H and R 3b  is selected from the group consisting of:
 (a) —OH, 
 (b) -heteroaryl, 
 (c) —O-heteroaryl, 
 (d) -heterocycle, 
 (e) -aryl, and 
 (f) —O-aryl; 
 
         wherein each of the heteroaryl of choices (b) and (c), the heterocycle of choice (d) and the aryl of choices (e) and (f) is optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein the heterocycle of choice (d) is additionally optionally substituted with 1 to 2 oxo groups; or 
         R 3a  and R 3b  together represent oxo; 
         R 4  is selected from the group consisting of:
 (a) —C 1-4 alkyl, 
 (b) -haloC 1-4 alkyl, 
 (c) —OH, 
 (d) —O—C 1-4 alkyl, 
 (e) —O-haloC 1-4 alkyl, and 
 (f) -halogen; 
 
         R 5  is —C 3-12 cycloalkyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) —C 1-4 alkyl, 
 (ii) -halogen, 
 (iii) —O—C 1-4 alkyl, 
 (iv) —S—C 1-4 alkyl; 
 
         wherein each of the alkyl group of choices (i), (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         each R 7  and each R 8  are independently selected from the group consisting of:
 (a) —H, 
 (b) —C 1-6 alkyl, 
 (c) —C 0-6 alkyl-C 3-12 cycloalkyl, 
 (d) —C 0-6 alkyl-heterocyclyl, 
 (e) —C 0-6 alkyl-heteroaryl, 
 (f) —C 0-6 alkyl-aryl, 
 (g) —C 2-6 alkenyl, and 
 (h) —C 2-6 alkynyl, 
 
         wherein the alkyl group of choices (b)-(f), the alkenyl group of choice (g), the cycloalkyl group of choice (c), and the alkynyl group of (h) is optionally substituted with 1 to 3 groups independently selected from:
 (i) -halogen, 
 (ii) —C 1-4 alkyl, 
 (iii) —C(O)C 1-4 alkyl, 
 (iv) —OH, 
 (v) —OC 1-4 alkyl, 
 (vi) —SH, 
 (vii) —SC 1-4 alkyl, 
 (viii) —NH 2 , 
 (ix) —NH(C 1-4 alkyl), and 
 (x) —N(C 1-4 alkyl)(C 1-4 alkyl); or 
 
         R 7 , R 8  and the nitrogen atom to which they are attached together form a 3- to 7-membered monocyclic or 6- to 11-membered bicyclic heterocycle optionally having an additional heteroatom selected from O, S(O) p , and NR 9 , and wherein said heterocycle is optionally substituted with 1 to 2 groups independently selected from halogen; 
         R 9  is selected from the group consisting of:
 (a) —H, 
 (b) —C 1-4 alkyl, 
 (c) —C(O)—C 1-4 alkyl, 
 (d) —C(O)NH 2 , 
 (e) —C(O)—NH(C 1-4 alkyl), 
 (f) —C(O)—N(C 1-4 alkyl) 2 , and 
 (g) —C(O)O—C 1-4 alkyl; 
 
         R 10 , R 11 , and R 12  are independently selected from the group consisting of: H, halogen, —OH and —C 1-6  alkyl; or 
         R 10 , R 11  and the atom to which they are attached together form a C 3-12 cycloalkyl or a heterocyclyl group; 
         k is 0, 1, 2, 3 or 4; 
         n and m are independently selected from 0, 1, 2 and 3, with the proviso that n+m is 0, 1, 2, 3 or 4; 
         p is 0, 1 or 2. 
       
     
     
         12 . A compound of  claim 11  wherein
 R 3b  is selected from the group consisting of:
 (a) —OH, 
 (b) 
 
 
       
         
           
           
               
               
           
         
         
           (c) —O-heteroaryl, and 
           (d) 
         
       
       
         
           
           
               
               
           
         
         wherein HAr is heteroaryl and Hcyl is heterocycle, and HAr, heteroaryl of choice (c), and Hcyl are each optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein Hcyl is additionally optionally substituted with 1 to 2 oxo groups. 
       
     
     
         13 . A compound of  claim 11  or  12  wherein
 R 3b  is selected from the group consisting of:
 (a) 
 
 
       
         
           
           
               
               
           
         
         
            and 
           (b) 
         
       
       
         
           
           
               
               
           
         
         wherein HAr is heteroaryl and Hcyl is heterocycle, and HAr and Hcyl are each optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein Hcyl is additionally optionally substituted with 1 to 2 oxo groups. 
       
     
     
         14 . A compound of any of  claims 11  through  13  wherein W is —C(O)C(O)NH 2 . 
     
     
         15 . A compound of any of  claims 11  through  14  wherein Y is —C(O)—. 
     
     
         16 . A compound of any one of  claims 11  through  14  wherein
 W is —C(O)C(O)NH 2 ; 
 Y is —C(O)—; and 
 R 3b  is selected from the group consisting of:
 (a) 
 
 
       
         
           
           
               
               
           
         
         
            and 
           (b) 
         
       
       
         
           
           
               
               
           
         
         wherein HAr is heteroaryl and Hcyl is heterocycle, and each heteroaryl and heterocycle is optionally substituted with 1 to 3 groups independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —OH, 
 (iii) —CR 10 R 11 R 12 , 
 (iv) —C 0-3 alkyl-NHSO 2 —C 1-4 alkyl, 
 (v) —C 0-3 alkyl-SO 2 —C 1-4 alkyl, 
 (vi) —C 0-3 alkyl-C(O)O—C 1-4 alkyl, and 
 (vii) —CN; 
 
         wherein the heterocycle is additionally substituted with 1 to 2 oxo groups. 
       
     
     
         17 . A compound of  claim 1  having the formula (Ib): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof, wherein 
         W is selected from the group consisting of: —B(OH) 2  and —C(O)C(O)NR 7 R 8 ; 
         X is selected from the group consisting of: —O—, —S(O) p — and —N(C(O)OR 6 )—; 
         Y is selected from the group consisting of: —C(O)—, —SO 2 —, and —NHC(O)—; 
         R 1  is selected from the group consisting of:
 (a) -aryl, 
 (b) -heteroaryl, 
 
         wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) -halogen, 
 (ii) —CN, 
 (iii) —C 1-6 alkyl, 
 (iv) —C 0-6 alkyl-R 5 , 
 (v) —C 2-6 alkenyl, 
 (vi) —C 2-6 alkynyl, 
 (vii) —C(O)R 7 , 
 (viii) —CO 2 R 7 , 
 (ix) —CONR 7 R 8 , 
 (x) —OH, 
 (xi) —O—C 1-6 alkyl, 
 (xii) —O—C 0-6 alkyl-R 5 , 
 (xiii) —SH, 
 (xiv) —S(O) p —C 1-6 alkyl, 
 (xv) —S(O) p —C 0-6 alkyl-R 5 , 
 (xvi) —S(O) 2 NR 7 R 8 , 
 (xvii) —NO 2 , 
 (xviii) —NR 7 R 8 , 
 (xix) —NHC(O)R 7 , 
 (xx) —NHC(O)OR 7 , 
 (xxi) —NHC(O)N 7 R 8 , 
 (xxii) —NHSO 2 C 1-6 alkyl, and 
 (xxiii) —NHSO 2 C 0-6 alkyl-R 5 , 
 
         wherein each of the alkyl group of choices (iii), (iv), (xi), (xii), (xiv), (xv), (xxii) and (xxiii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         R 2  is selected from the group consisting of:
 (a) —C 3-8 alkyl and 
 (b) —C 0-6 alkyl-R 5 , 
 
         wherein each of the alkyl group of choices (a) and (b) is optionally substituted with 1 to 5 substituents independently selected from:
 (i) -halogen, 
 (ii) -haloC 1-4 alkyl, 
 (iii) —NR 2 R 8 , 
 (iv) —OH, 
 (v) —O—C 1-4 alkyl, 
 (vi) —SH, 
 (vii) —S—C 1-4 alkyl; 
 (viii) —NR 7 SO 2 C 1-4 alkyl, and 
 (ix) —NR 7 C(O)OR 7 , 
 
         R 4  is selected from the group consisting of:
 (a) —C 1-4 alkyl, 
 (b) -haloC 1-4 alkyl, 
 (c) —OH, 
 (d) —O—C 1-4 alkyl, 
 (e) —O-haloC 1-4 alkyl, and 
 (f) -halogen; 
 
         R 5  is selected from the group consisting of:
 (a) —C 3-12 cycloalkyl, 
 (b) -aryl, 
 (c) -heteroaryl, and 
 (d) -heterocyclyl, 
 
         wherein each of choices (a) to (d) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) —C 1-4 alkyl, 
 (ii) -halogen, 
 (iii) —NR 7 R 8 , 
 (iv) —OH, 
 (v) —O—C 1-4 alkyl, 
 (vi) —SH, and 
 (vii) —S—C 1-4 alkyl; 
 
         wherein each of the alkyl group of choices (i), (v) and (vii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl; 
         R 6  is selected from the group consisting of:
 (a) —C 1-6 alkyl, and 
 (b) —C 0-6 alkyl-aryl; 
 
         each R 7  and each R 8  are independently selected from the group consisting of:
 (a) —H, 
 (b) —C 1-6 alkyl, 
 (c) —C 0-6 alkyl-C 3-12 cycloalkyl, 
 (d) —C 0-6 alkyl-heterocyclyl, 
 (e) —C 0-6 alkyl-heteroaryl, 
 (f) —C 0-6 alkyl-aryl, 
 (g) —C 2-6 alkenyl, and 
 (h) —C 2-6 alkynyl, 
 
         wherein the alkyl group of choices (b)-(f), the alkenyl group of choice (g), the cycloalkyl group of choice (c), and the alkynyl group of (h) is optionally substituted with 1 to 3 groups independently selected from:
 (i) -halogen, 
 (ii) —C 1-4 alkyl, 
 (iii) —C(O)C 1-4 alkyl, 
 (iv) —OH, 
 (v) —OC 1-4 alkyl, 
 (vi) —SH, 
 (vii) —SC 1-4 alkyl, 
 (viii) —NH 2 , 
 (ix) —NH(C 1-4 alkyl), and 
 (x) —N(C 1-4 alkyl)(C 1-4 alkyl); or 
 
         R 7 , R 8  and the nitrogen atom to which they are attached together form a 3- to 7-membered monocyclic or 6- to 11-membered bicyclic heterocycle optionally having an additional heteroatom selected from O, S(O) p , and NR 9 , and wherein said heterocycle is optionally substituted with 1 to 2 groups independently selected from halogen; 
         R 9  is selected from the group consisting of:
 (a) —H, 
 (b) —C 1-4 alkyl, 
 (c) —C(O)—C 1-4 alkyl, 
 (d) —C(O)NH 2 , 
 (e) —C(O)—NH(C 1-4 alkyl), 
 (f) —C(O)—N(C 1-4 alkyl) 2 , and 
 (g) —C(O)O—C 1-4 alkyl; 
 
         R 10 , R 11 , and R 12  are independently selected from the group consisting of: H, halogen, —OH and —C 1-6  alkyl; or 
         R 10 , R 11  and the carbon atom to which they are attached together form a C 3-12 cycloalkyl or a heterocyclyl group; 
         k is 0, 1, 2, 3 or 4; 
         n and m are independently selected from 0, 1, 2 and 3, with the proviso that n+m is 0, 1, 2, 3 or 4; 
         p is 0, 1 or 2. 
       
     
     
         18 . A compound of  claim 17  wherein
 R 2  is —C 1-3 alkyl-R 5 , and 
 R 5  is —C 3-12 cycloalkyl, optionally substituted with 1 to 3 substituents independently selected from the group consisting of:
 (i) —C 1-4 alkyl, 
 (ii) -halogen, 
 (iii) —O—C 1-4 alkyl, 
 (iv) —S—C 1-4 alkyl; 
 
 wherein each of the alkyl group of choices (i), (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
 
     
     
         19 . A compound of any of  claims 17  through  18  wherein
 W is —C(O)C(O)NH 2 ; 
 X is —O— or —S(O) p —; and 
 Y is —C(O)—. 
 
     
     
         20 . A compound of any of  claims 1  through  19  wherein
 R 1  is selected from the group consisting of:
 (e) phenyl, 
 (f) naphthyl, 
 (g) 5- or 6-membered monocyclic heteroaryl ring, said ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms; and 
 (h) 8-, 9-, or 10-membered fused bicyclic heteroaryl ring, said ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms; 
 
 wherein each of choices (a)-(d) is optionally substituted with 1 or 2 substituents independently selected from the group consisting of:
 (vi) -halogen, 
 (vii) —CONR 7 R 9 , 
 (viii) —S(O) p —C 1-6 alkyl, 
 (ix) —S(O) p —C 0-6 alkyl-R 5 , 
 (x) —S(O) 2 NR 7 R 8 , 
 
 wherein each of the alkyl group of choices (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
 
     
     
         21 . A compound of any of  claims 1  through  20  wherein n and m are each 1, and k is 0. 
     
     
         22 . A compound of  claim 1  having the formula (Ic): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof, wherein 
         X is O or S(O) n ; 
         R 1  is selected from the group consisting of:
 (i) phenyl, 
 (j) naphthyl, 
 (k) 5- or 6-membered monocyclic heteroaryl ring, said ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms; and 
 (l) 8-, 9-, or 10-membered fused bicyclic heteroaryl ring, said ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms; 
 
         wherein each of choices (a)-(d) is optionally substituted with 1 or 2 substituents independently selected from the group consisting of:
 (xi) -halogen, 
 (xii) —CONR 7 R 8 , 
 (xiii) —S(O) p —C 1-6 alkyl, 
 (xiv) —S(O) p —C 0-6 alkyl-R 5 , 
 (xv) —S(O) 2 NR 7 R 8 , 
 
         wherein each of the alkyl group of choices (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
       
     
     
         23 . A compound of  claim 22  wherein R 1  is selected from naphthyl, imidazo[1,2-a]pyridinyl, quinolinyl, indazolyl, benzotriazolyl, benzisoxazolyl, benzoxazolyl, benzthiazolyl, benzofuranyl, indolyl, benzimidazolyl, and isoquinolinone. 
     
     
         24 . A compound of  claim 22  wherein R 1  is phenyl optionally substituted with 1 or 2 substituents independently selected from the group consisting of:
 (vi) -halogen, 
 (vii) —CONR 7 R 8 , 
 (viii) —S(O) p —C 1-6 alkyl, 
 (ix) —S(O) p —C 0-6 alkyl-R 5 , 
 (x) —S(O) 2 NR 7 R 8 , 
 
       wherein each of the alkyl group of choices (iii) and (iv) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 7 , —CO 2 R 7 , —CONR 7 R 8 , —NR 7 R 8 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl. 
     
     
         25 . A compound of  claim 1  selected from the group consisting of:
 tert-butyl 4-((2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-4-(2-amino-2-oxoacetyl)piperidine-1-carboxylate; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)imidazo[1,2-a]pyridine-6-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(4-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)quinoline-3-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indazole-7-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((2-methoxyethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(4-((2-amino-2-oxoethyl)sulfonyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(6-methoxy-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(1-methoxy-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(6-(difluoromethoxy)-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(6-(trifluoromethoxy)-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(2-hydroxypropan-2-yl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(2,2,2-trifluoro-1,1-dihydroxyethyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((2R)-3-cyclohexyl-2-(4-(2,2,2-trifluoro-1-hydroxyethyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)benzo[d]isoxazole-3-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)benzo[d]oxazole-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)benzo[d]thiazole-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(benzofuran-5-carboxamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indole-6-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indole-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-fluorobenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(3-hydroxyoxetan-3-yl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(isopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(cyclopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indazole-6-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-benzo[d][1,2,3]triazole-6-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-benzo[d]imidazole-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-benzo[d]imidazole-6-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-fluoro-4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-methyl-4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(cyclopentylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(ethylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((trifluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((2,2-difluoroethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N,N-dimethylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-sulfamoylbenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(pyrrolidin-1-ylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N,N-diethylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(morpholinosulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(2-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(4-(cyclobutylsulfonyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(4-(N-cyclobutylsulfamoyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(2,2,2-trifluoroethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(prop-2-yn-1-yl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(cyclopropylmethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(2,2-difluoroethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(6-(oxetan-3-yloxy)-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(6-(oxetan-3-yl)-2-naphthamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(3,3-difluorocyclobutyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-phenylureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(naphthalen-2-yl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(4-(trifluoromethyl)phenyl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(1-methyl-1H-indol-4-yl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(3-(3-chloro-4-fluorophenyl)ureido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-cyclohexylureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(naphthalen-1-yl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(4-phenyltetrahydro-2H-pyran-4-yl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(3-benzylureido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-2-(3-(4-cyanophenyl)ureido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(4-(methylsulfonyl)phenyl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(naphthalene-2-sulfonamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(3,4-difluorophenylsulfonamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(difluoromethoxy)phenylsulfonamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(3-(2-amino-2-oxoacetyl)tetrahydrofuran-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)oxepan-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N—((R)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N—((S)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)picolinamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(ethylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)imidazo[1,2-a]pyridine-6-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1-oxo-1,2-dihydroisoquinoline-3-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(cyclopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-2-methyl-2H-benzo[d][1,2,3]triazole-5-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1-methyl-1H-benzo[d][1,2,3]triazole-6-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1-methyl-1H-benzo[d][1,2,3]triazole-5-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((2-methoxyethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-benzo[d][1,2,3]triazole-5-carboxamide; 
 N 1 —((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)terephthalamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-2-benzamido-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)isonicotinamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(prop-2-yn-1-yl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H1-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(3,3-difluorocyclobutyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H1-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(oxetan-3-yl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(morpholinosulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-methylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N,N-dimethylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-ethylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(isopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((cyclopropylmethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(2,2-difluoroethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(4-((4-acetylpiperazin-1-yl)sulfonyl)benzamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(pyrrolidine-1-carbonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-(cyclobutylsulfonyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N 1 —((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-N 4 ,N 4 -dimethylterephthalamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(1-methylcyclopropyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((4-methylpiperazin-1-yl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-(azetidin-1-ylsulfonyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(pyrrolidin-1-ylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(cyclopropylmethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-(N-cyclobutylsulfamoyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(2,2,2-trifluoroethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(tetrahydro-2H-thiopyran-4-yl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((3,3-difluoroazetidin-1-yl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(4-(2-oxa-6-azaspiro[3.3]heptan-6-ylsulfonyl)benzamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(3,3-dimethyl-2-oxobutyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(pyrrolidin-1-ylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)quinoline-3-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indazole-7-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indazole-6-carboxamide; 
 N 1 —((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)terephthalamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-nitrobenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-bromobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-chloro-2,5-difluorobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(3,4-dichlorobenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-6-hydroxynicotinamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1-hydroxyisoquinoline-3-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-7-fluoroquinoline-3-carboxamide; 
 N—((R)-1-((2S,4S)-2-((4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-7-chloroquinoline-3-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-(N-cyclobutylsulfamoyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(spiro[3.3]heptan-2-yl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-(2,2-difluoroethyl)sulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-2-(4-(N-(tert-butyl)sulfamoyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-phenylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropyl-N-methylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropyl-N-ethylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4R)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopentylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N,N-dicyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(naphthalene-2-sulfonamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(3-(naphthalen-2-yl)ureido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)-1-oxidotetrahydro-2H-thiopyran-4-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N-(4-(2-amino-2-oxoacetyl)-1-oxidotetrahydro-2H-thiopyran-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(3-(2-amino-2-oxoacetyl)tetrahydrothiophen-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(3-(2-amino-2-oxoacetyl)-1-oxidotetrahydrothiophen-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(3-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydrothiophen-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(3-(2-amino-2-oxoacetyl)-1,1-dioxidotetrahydro-2H-thiopyran-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((R)-4-((2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((S)-4-((2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((R)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-(cyclopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((S)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-(cyclopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((R)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)—N—((S)-4-(2-amino-2-oxoacetyl)oxepan-4-yl)-1-((R)-3-cyclohexyl-2-(4-(N-cyclopropylsulfamoyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide; 
 (2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-hydroxypyrrolidine-2-carboxamide; 
 (S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-oxopyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(6-oxopyridazin-1(6H)-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(1,3-dioxoisoindolin-2-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-((5-methylisoxazol-3-yl)oxy)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(3-chloro-6-oxopyridazin-1(6H)-yl)pyrrolidine-2-carboxamide; 
 (2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-(2-amino-2-oxoacetyl)tetrahydro-2H-pyran-4-yl)-4-(2-oxopyridin-1(2H)-yl)pyrrolidine-2-carboxamide; and 
 (4-((2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)tetrahydro-2H-pyran-4-yl)boronic acid;
 or a pharmaceutically acceptable salt, solvate, salt of the solvate, or prodrug thereof. 
 
 
     
     
         26 . A pharmaceutical composition comprising a compound of any one of  claims 1 - 25  and a pharmaceutically acceptable carrier. 
     
     
         27 . A method of preventing, or treating a disease of the eye selected from dry-AMD, wet-AMD, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells, comprising: administering to a subject in need thereof a therapeutically effective amount of a compound according to  claim 1 - 25  or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof, or the pharmaceutical composition of  claim 26 . 
     
     
         28 . The method of preventing a disease of the eye, according to  claim 27  wherein the method of prevention is selected from delaying the onset of disease and reducing the risk of developing a disease of the eye, wherein the disease of the eye is selected from dry-AMD, wet-AMD, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells. 
     
     
         29 . The method of treating a disease of the eye according to  claim 27  wherein the method is selected from controlling, alleviating, and slowing the progression of, wherein the disease is selected from dry-AMD, wet-AMD, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells. 
     
     
         30 . The method according to any of  claims 27  to  29  wherein the disease is geographic atrophy. 
     
     
         31 . A method of inhibiting HTRA1 protease activity in an eye comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to  claims 1 - 25  or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof, or the pharmaceutical composition of  claim 26 .